• 1. Emerging themes in soft matter: responsive and active soft materials
  Julia M. Yeomans Soft Matter, 2010,6, 703-704
• 2. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
• 3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 4. eMethylsorb: rapid quantification of DNA methylation in cancer cells on screen-printed gold electrodes
  Kevin M. Koo,Abu Ali Ibn Sina,Laura G. Carrascosa,Muhammad J. A. Shiddiky Analyst, 2014,139, 6178-6184
• 5. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Furans Nitrofurans

Recent Advances in the Study of 2-Ethynyl-5-Nitrofuran (CAS: 19275-29-7) in Chemical Biology and Pharmaceutical Research

The compound 2-ethynyl-5-nitrofuran (CAS: 19275-29-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This heterocyclic compound, characterized by a nitrofuran core with an ethynyl substituent, exhibits notable reactivity and biological activity, making it a promising candidate for drug development and chemical biology studies. Recent studies have explored its role as a versatile building block in medicinal chemistry, as well as its potential as an antibacterial and anticancer agent.

One of the key areas of research involving 2-ethynyl-5-nitrofuran focuses on its mechanism of action and biological targets. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits potent inhibitory effects against bacterial nitroreductases, enzymes that play a crucial role in antibiotic resistance. The study revealed that the ethynyl group at the 2-position significantly enhances the compound's ability to interact with the active site of these enzymes, suggesting its potential as a novel antibiotic adjuvant to combat resistant bacterial strains.

In the field of cancer research, recent investigations have highlighted the compound's ability to function as a prodrug that is selectively activated in hypoxic tumor environments. A 2024 study in Chemical Science reported that 2-ethynyl-5-nitrofuran can be efficiently reduced by hypoxic tumor cell reductases to generate cytotoxic species, leading to selective tumor cell death while sparing normal cells. This property makes it particularly attractive for developing targeted cancer therapies with reduced side effects.

From a synthetic chemistry perspective, researchers have developed novel methodologies for incorporating 2-ethynyl-5-nitrofuran into more complex molecular architectures. A recent breakthrough published in Organic Letters (2024) described a copper-catalyzed click chemistry approach that enables efficient conjugation of this compound with various biomolecules, opening new possibilities for creating targeted drug delivery systems and chemical probes for biological studies.

The compound's safety profile and pharmacokinetic properties have also been the subject of recent investigations. While early studies indicate good stability and reasonable bioavailability, ongoing research is focusing on optimizing its formulation to improve solubility and tissue distribution. Several research groups are currently exploring nanoparticle-based delivery systems to enhance the therapeutic potential of 2-ethynyl-5-nitrofuran derivatives.

Looking forward, the unique properties of 2-ethynyl-5-nitrofuran (CAS: 19275-29-7) position it as a versatile scaffold for multiple therapeutic applications. Current research directions include the development of novel antimicrobial agents, hypoxia-activated prodrugs, and chemical tools for studying redox biology. As understanding of its molecular interactions deepens, this compound is expected to play an increasingly important role in both drug discovery and chemical biology research.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)